New Trends in Nucleoside Biotechnology

Обложка

Цитировать

Полный текст

Аннотация

This review focuses on new trends in nucleoside biotechnology, which have emerged during the last decade. Continuously growing interest in the study of this class of compounds is fueled by a number of factors: (i) a growing need for large-scale production of natural 2'-deoxy-β-D-ribonucleosides as well as their analogs with modifications in the carbohydrate and base fragments, which can then be used for the synthesis and study of oligonucleotides, including short-interfering RNA (siRNA), microRNA (miRNA), etc.; (ii) a necessity for the development of efficient practical technologies for the production of biologically important analogs of natural nucleosides, including a number of anticancer and antiviral drugs; (iii) a need for further study of known and novel enzymatic transformations and their use as tools for the efficient synthesis of new nucloside analogs and derivates with biomedical potential. This article will review all of these aspects and also include a brief retrospect of this field of research.

Полный текст

New Trends in Nucleoside Biotechnology
×

Список литературы

  1. Levene P.A., Tipson R.S. // J. Biol. Chem. 1935. V. 111 (2). P. 313-323.
  2. Levene P.A., Mandel H. // Ber. Deutsch. Chem. Ges. 1908. V. 41 (2). P. 1905-1909.
  3. Levene P.A., Jacobs W.A. // Ber. Deutsch. Chem. Ges. 1909. V. 42 (2). P. 2469-2473.
  4. Levene P.A., Jacobs W.A. // Ber. Deutsch. Chem. Ges. 1909. V. 42 (2). P. 2474-2478.
  5. Levene P.A., Jacobs W.A. //Ber. Deutsch. Chem. Ges. 1911. V. 44 (1). P. 746-753.
  6. Levene P.A., London E.S. // J. Biol. Chem. 1929. V. 83 (2). P. 793-802.
  7. Levene P.A., Mori T. // J. Biol. Chem. 1929. V. 83 (2). P. 803-816.
  8. Fischer E., Helferich B. // Ber. Deutsch. Chem. Ges. 1914. V. 47 (1). P. 210-235.
  9. Gulland J.M., Story L.F. // J. Chem. Soc. 1938. P. 259-261.
  10. Michelson A.M. The chemistry of nucleosides and nucleotides. London: Acad. Press, 1963. 600 p.
  11. Lukevics E., Zablocka A. Nucleoside Synthesis: Organosilicon Methods. Chichester: Ellis Horwood, 1991. 496 p.
  12. Vorbruggen H., Ruh-Pohlenz C. // Organic reactions / Eds Paquette L.A. et al. New York: Wiley, 2000. V. 55. P. 1-630.
  13. Bardos Th.J. // Topics Curr. Chem. 1974. V. 52. P. 63-98.
  14. Langen P. Antimetabolites of nucleic acid metabolism. New York: Gordon and Breach, 1975. 273 p.
  15. Suhadolnik R.J. // Progr. Nucleic Acids Res. Mol. Biol. 1979. V. 22. P. 193-291.
  16. De Clercq E. // J. Med Chem. 2010. V. 53 (4). P. 1438-1450.
  17. De Clercq E. // Med. Res. Rev. 2009. V. 29 (4). P. 611-645.
  18. Modified nucleosides_in biochemistry, biotechnology and medicine / Ed. Herdewijn Piet. Wiley-VCH, 2008. 900 p.
  19. Famulok M., Hartig J.S., Mayer G. // Chem Rev. 2007. V. 107. P. 3715-3743.
  20. Elion G.B. // Science. 1989. V. 244. P. 41-46.
  21. Gandhi V., Plunkett W. // Curr. Opinion Oncol. 2006. V. 18. P. 584-590.
  22. Bonate P.L., Arthaud L., Cantrell, Jr., W.R., et al. // Nature Rev. Drug Discov. 2006. V. 5. P. 855-863.
  23. De Clercq E. // Intern. J. Antimicrob. Agents. 2009. V. 33. P. 307-320.
  24. Mikhailopulo I.A. // Current Org. Chem. 2007. V. 11. P. 317-335.
  25. Montgomery J.A. // J. Med. Chem. 1980. V. 23 (10). P. 1063-1067.
  26. Montgomery J.A. // Heterocycles. 1984. V. 21 (1). P. 137-150.
  27. De Crercq E. // Nat. Rev. Drug Discov. 2002. V. 1. P. 13-25.
  28. Ftorafur. An anticancer drug. (Pamphlet) / Compiled by Germane S., et al. Riga: Zinatne, 1979. 358 p.
  29. Buie L.B., Epstein S.S., Lindley C.M. // Clin. Therapeutics. 2007. V. 29 (9). P. 1887-1899.
  30. De Clercq E. // Nature Rev. Drug Discovery. 2007. V. 6. P. 1001-1018.
  31. De Clercq E. // Antiviral Res. 2010. V. 85 (1). P. 19-24.
  32. De Clercq E. // Adv. Virus Res. 2009. V. 73. P. 1-53.
  33. Ferir G., Kaptein S., Neyts J., De Clercq E. // Rev. Med. Virol. 2008. V. 18. P. 19-34.
  34. Vivet-Boudou V., Didierjean J., Isel C., Marquet R. // Cell. Mol. Life Sci. 2006. V. 63. P. 163-186.
  35. Schaeffer H.J., Bhargava P.S. // Biochemistry. 1965. V. 4 (1). P. 71-76.
  36. Schaeffer H.J., Vince R. // J. Med. Chem. 1965. V. 8 (1). P. 33-35.
  37. Schaeffer H.J., Gurwara S., Vince R., Bittner S. // J. Med. Chem. 1971. V. 14 (4). P. 367-369.
  38. Schaeffer H. J., Beauchamp L., de Miranda P., et al. // Nature. 1978. V. 272. P. 583-585.
  39. De Clercq E., Holy A. // Nature Rev. Drug Discovery. 2005. V. 4. P. 928-940.
  40. Levene P.A., Medigreceanu F. // J. Biol. Chem. 1911. V. 9 (3). P. 375-387.
  41. Levene P.A., Medigreceanu F. // J. Biol. Chem. 1911. V. 9 (3). P. 389-402.
  42. Levene P.A., Yamagawa M., Weber I. // J. Biol. Chem. 1924. V. 60 (3). P. 693-706.
  43. Levene P.A., Weber I. // J. Biol. Chem. 1924. V. 60 (3). P. 707-715.
  44. Levene P.A., Weber I. // J. Biol. Chem. 1924. V. 60 (3). P. 717-720.
  45. Jones W. // J. Biol. Chem. 1911. V. 9 (2). P. 129-137.
  46. Jones W. // J. Biol. Chem. 1911. V. 9 (2). P. 169-180.
  47. Levene P.A., Yamagawa M., Weber I. // J. Biol. Chem. 1924. V. 60 (3). P. 693-706.
  48. Levene P.A., Weber I. // J. Biol. Chem. 1924. V. 60 (3). P. 707-715.
  49. Levene P.A., Weber I. // J. Biol. Chem. 1924. V. 60 (3). P. 717-720.
  50. Bzowska A., Kulikowska E., Shugar D. // Pharm. Ther. 2000. V. 88. P. 349-425.
  51. Kalckar H.M. // Federation Proc. 1945. V. 4. P. 248-250.
  52. Kalckar H.M. // J. Biol. Chem. 1947. V. 167 (2). P. 477-486.
  53. Manson L.A., Lampen J.O. // J. Biol. Chem. 1951. V. 193 (2). P. 539-547.
  54. Araki T., Ikeda I., Matoishi K., et al. Eur. Pat. Appl. 2002, 32 p. CODEN: EPXXDW EP 1254959 A2 20021106 CAN 137:348820 AN 2002:847552 CAPLUS
  55. Usowa E., Maltseva T., Foldesi A., et al. // J. Mol. Biol. 2004. V. 344. P. 1347-1358.
  56. Lewkowics E.S., Iribarren A.M. // Curr. Org. Chem. 2006. V. 10 (11). P. 1197-1215.
  57. Friedkin M., Roberts D. // J. Biol. Chem. 1954. V. 207 (1). P. 245-256.
  58. Friedkin M., Roberts D. // J. Biol. Chem. 1954. V. 207 (1). P. 257-266.
  59. Duschinsky R., Pleven E., Rlalbica J., Heidelberger C. // Abstracts, 132nd National Meeting of the American Chemical Society. New York, 1957. P. 19-C.
  60. Duschinsky R. US Patent 3,168,513 (1965).
  61. Hoffer M., Duschinsky R., Fox J.J., Yung N. // J. Am. Chem. Soc. 1959. V. 81 (15). P. 4112-4113.
  62. Hoffer M. // Chem. Ber. 1960. V. 93. P. 2777-2781.
  63. Heidelberger C., Parsons D.G., Remy D.C. // J. Am. Chem. Soc. 1962. V. 84 (18). P. 3597-3598.
  64. Heidelberger C., Parsons D.G., Remy D.C. // J. Med. Chem. 1964. V. 7. P. 1-5.
  65. Friedkin M., Kalckar H.M. // The Enzymes, 2nd ed. / Eds Boyer P.D., Lardy H., Myrback K. New York: Acad. Press, 1961. V. 5. P. 237-255.
  66. Heidelberger C., Ansfield F.J. // Cancer Res. 1963. V. 23. P. 1226-1243.
  67. Heidelberger C. // Progr. Nucleic Acid. Res. Mol. Biol. 1965. V. 4. P. l-50.
  68. Heidelberger C. // Annu. Rev. Biochem. 1975. V. 44. P. 79-121.
  69. Kalinichenko E.N., Barai V.N., Bokut S.B., et al. // Biotechnol. Lett. 1989. V. 11. P. 621-626.
  70. Tuttle J.V., Tisdale M., Krenitsky T.A. // J. Med. Chem. 1993. V. 36. P. 119-125.
  71. Tuttle J.V., Krenitsky T.A. EP 0285432 B1 (Wellcome Found, GB), Publ. 1988-10-05.
  72. Zinchenko A.I., Barai V.N., Bokut S.B., et al. // Appl. Microbiol. Biotechnol. 1990. V. 32. P. 658-661.
  73. Zaitsewa G.V., Zinchenko A.I., Barai V.N., et al. // Nucleosides Nucleotides. 1999. V. 18. P. 687-688.
  74. Zaitseva G.V., Kvasyuk E.I., Vaaks E.V., et al. // Nucleosides Nucleotides. 1994. V. 13. P. 819-834.
  75. Esipov R.S., Gurevich A.I., Chuvikovsky D.V., et al. // Protein Expes. Purif. 2002. V. 24. P. 56-60.
  76. Roivainen J., Elizarova T., Lapinjoki S., et al. // Nucleosides, Nucleotides, &.Nucleic Acids. 2007. V. 26. P. 905-909.
  77. Bzowska A., Kulikowska E., Shugar D. // Z. Naturforsch. 1990. V. 45c. P. 59-70.
  78. Koellner G., Bzowska A., Wielgus-Kutrowska B., et al. // J. Mol. Biol. 2002. V. 315. P. 351-371.
  79. Krenitsky T.A., Rideout J.L., Koszalka G.W., et al. // J. Med. Chem. 1982. V. 25. P. 32-35.
  80. Krenitsky T.A., Rideout J.L., Chao E.Y., et al. // J. Med. Chem. 1986. V. 29. P. 138-143.
  81. Hennen W.J., Wong C.-H. // J. Org. Chem. 1989. V. 54. P. 46924695.
  82. Mikhailopulo I.A., Zinchenko A.I., Bokut S.B., et al. // Biotechnol. Lett. 1992. V. 14 (10). P. 885-890.
  83. Mikhailopulo I.A., Kazimierczuk Z., Zinchenko A.I., et al. // Nucleosides Nucleotides. 1995. V. 14 (3-5). P. 477-480.
  84. Mikhailopulo I.A., Kazimierczuk Z., Zinchenko A.I., et al. // Nucl. Acids Symp. Ser. N 31. 1994. P. 83-84.
  85. Doskocil J., Holy A. // Coll. Czech. Chem. Commun. 1977. V. 42. P. 370-383.
  86. Rosemeyer H., Seela F. // J. Org. Chem. 1987. V. 52. P. 5136-5143.
  87. Colacino J. M., DeLong D. C., Nelson J. R., et al. // Antimicrob. Agents Chemother. 1990. V. 34. P. 2156-2163.
  88. Ehlhardt W.J., Wheeler W.J., Breau A.P., et al. // Drug Metabolism Disposition. 1993. V. 21. P. 162-170.
  89. Hayden F.G., Tunkel A.R., Treanor J.J., et al. // Antimicrob. Agents. Chenther. 1994. V. 38. P. 1178-1181.
  90. Ling F., Inoue Y., Kimura A. // Appl. Envirom. Microbiol. 1990. V. 56 (12). P. 3830-3834.
  91. Shirae H., Yokozeki K. // Agric. Biol. Chem. 1991. V. 55 (7). P. 18491857.
  92. Cardinaud R. // Methods Enzymol. 1978. V. 51. P. 446-455.
  93. Anand R., Kaminski P.A., Ealick S.E. // Biochemistry. 2004. V. 43. P. 2384-2393.
  94. McNutt W.S. // Biochem. J. 1952. V. 50. P. 384-397.
  95. Roush A.H., Betz R.F. // J. Biol. Chem. 1958. V. 233. P. 261-266.
  96. Beck W.S., Levin M. // J. Biol. Chem. 1963. V. 238. P. 702-709.
  97. Holguin L., Cardinaud R. // Eur. J. Biochem. 1975. V. 54. P. 505-514.
  98. Huang M.-C., Hatfield K., Roetker A.W., et al. // Biochem. Pharmacol. 1981. V. 30. P. 2663-2671.
  99. Holguin L., Cardinaud R., Salemink C.A. // Eur. J. Biochem. 1975. V. 54. P. 515-520.
  100. Carson D.A., Wasson D.B. // Biochem. Biophys. Res. Commun. 1988. V. 155. P. 829-834.
  101. Cook W.J., Short S.A., Ealick S.E. // J. Biol. Chem. 1990. V. 265. P. 2682-2683.
  102. Smar M., Short S.A., Wolfenden R. // Biochemistry. 1991. V. 30. P. 7908-7912.
  103. Freeman G.A., Shaver S.R., Rideout J.L., Short S.A. // Bioorg. Med. Chem. 1995. V. 3. P. 447-458.
  104. van Draanen N.A., Freeman G.A., Short S.A., et al. // J. Med. Chem. 1996. V. 39. P. 538-542.
  105. Armstrong S.R., Cook W.J., Short S.A., Ealick S.E. // Structure. 1996. V. 4. P. 97-107.
  106. Cheng J.C.-Y., Hacksell U., Daves G.D., Jr. // J. Org. Chem. 1985. V. 50 (15). P. 2778-2780.
  107. Walker J.A., II, Chen J.J., Wise D.S., Townsend L.B. // J. Org. Chem. 1996. V. 61 (6). P. 2219-2221.
  108. Porter D.J.T., Merrill B.M., Short S.A. // J. Biol. Chem. 1995. V. 270 (26). P. 15551-15556.
  109. Kaminski P.A. // J. Biol. Chem. 2002. V. 277. P. 14400-14407.
  110. Kaminski P.A., Dacher P., Dugue L., Pochet S. // J. Biol. Chem. 2008. V. 283. P. 20053-20059.
  111. Uerkvitz W. // Eur. J. Biochem. 1971. V. 23. P. 387-395.
  112. Chapeau M.-C., Marnett L.J. // Chem. Res. Toxicol. 1991. V. 4. P. 636-638.
  113. Muller M., Hutchinson L.K., Guengerich F.P. // Chem. Res. Toxicol. 1996. V. 9. P. 1140-1144.
  114. Parkin D.W. // J. Biol. Chem. 1996. V. 271 (6). P. 21713-21719.
  115. Pelle R., Schramm V.L., Parkin D.W. // J. Biol. Chem. 1998. V. 273 (4). P. 2118-2126.
  116. Tozzi M.G., Camici M., Mascia L., et al. // FEBS J. 2006. V. 273. P. 1089-1101.
  117. Ouwerkerk N., van Boom J.H., Lugtenburg J., Raap J. // Eur. J. Org. Chem. 2000. V. 5. P. 861-866.
  118. Ouwerkerk N., Steenweg M., De Ruijter M., et al. // J. Org. Chem. 2002. V. 67. P. 1480-1489.
  119. Ogawa J., Saito K., Sakai T., et al. // Biosci. Biotechnol. Biochem. 2003. V. 67. P. 933-936.
  120. Ishige T., Honda K., Shimizu S. // Curr. Opinion Chem. Biol. 2005. V. 9. P. 174-180.
  121. Horinouchi N., Ogawa J., Kawano T., et al. // Appl. Microbiol. Biotechnol. 2006. V. 71. P. 615-621.
  122. Horinouchi N., Ogawa J., Kawano T., et al. // Biosci. Biotechnol. Biochem. 2006. V. 70. P. 1371-1378.
  123. Horinouchi N., Ogawa J., Kawano T., et al. // Biotechnol. Letters. 2006. V. 28. P. 877-881.
  124. Horinouchi N., Kawano T., Sakai T., et al. // New Biotechnol. 2009. V. 26 (1/2). P. 75-82.
  125. Komatsu H., Awano H., Tanikawa H., et al. // Nucleosides Nucleotides Nucl. Acids. 2001. V. 20. P. 1291-1293.
  126. Komatsu H., Awano H. // J. Org. Chem. 2002. V. 67. P. 54195421.
  127. Komatsu H., Awano H., Ishibashi H., et al. // Nucl. Acids Res. Suppl. N 3. 2003. P. 101-102.
  128. Komatsu H., Araki T. // Nucleosides Nucleotides Nucl. Acids. 2005. V. 24 (5-7). P. 1127-1130.
  129. Komatsu H., Araki T. // Tetrahedron Lett. 2003. V. 44. P. 28992901.
  130. Taverna-Porro M., Bouvier L.A., Pereira C.A., et al. // Tetrahedron Lett. 2008. V. 49. P. 2642-2645.
  131. Yamada K., Matsumoto N., Hayakawa H. // Nucl. Acids Symp. Ser. No. 48. 2004. P. 45-46.
  132. Yamada K., Matsumoto N., Hayakawa H. // Nucleosides Nucleotides Nucl. Acids. 2009. V. 28. P. 1117-1130.
  133. Chuvikovsky D.V., Esipov R.S., Skoblov Y.S., et al. // Bioorg. Med. Chem. 2006. V. 14. P. 6327-6332.
  134. Esipov R.S., Gurevich A.I., Chuvikovsky D.V., et al. // Protein Expres. Purif. 2002. V. 24. P. 56-60.
  135. Mikhailopulo I.A., Konstantinova I.D., Fateev I.V., et al. // The 2nd International Conference on Drug Discovery & Therapy: Abstracts. Dubai, 2010. P. 123. (ICDDT_AbstractBook.pdf, p. 123).
  136. Miroshnikov A.I., Esipov R.S., Konstantinova, I.D., et al. // The Open Conference Proceedings Journal. 2010. V. 1. P. 98-102.
  137. de Lederkremer R.M., Nahmad V.B., Varela O. // J. Org. Chem. 1994. V. 59. P. 690-692.
  138. Euzen R., Ferrieres V., Plusquellec D. // J. Org. Chem. 2005. V. 70. P. 847-855.
  139. Hanessian S., Lou B. // Chem. Rev. 2000. V. 100. P. 4443-4463.
  140. MacDonald D.L. // J. Org. Chem. 1962. V. 27. P. 1107-1109.
  141. MacDonald D.L. // Carbohyd. Res. 1966. V. 3. P. 117-120
  142. MacDonald D.L. // Carbohyd. Res. 1968. V. 6. P. 376-381.
  143. Mendicino J., Hanna R. // J. Biol. Chem. 1970. V. 245. P. 6113-6124.
  144. Chittenden G.J.F. // Carbohyd. Res. 1972. V. 25. P. 35-41.
  145. Wright R.S., Khorana H.G. // J. Am. Chem. Soc. 1958. V. 80. P. 1994-1998.
  146. Maryanoff B.E., Reitz A.B., Nortey S.O. // Tetrahedron. 1988. V. 44. P. 3093-3106.
  147. Aspinall G.O., Cottrell I.W., Matheson N.K. // Can. J. Biochem. 1972. V. 50. P. 574-580.
  148. Larson R.A. // Seminar Oncol. 2007. V. 34 (Suppl. 5). P. S13-S20.
  149. Gandhi V., Plunkett W. // Curr. Opinion Oncol. 2006. V. 18. P. 584-590.
  150. Bonate P.L., Arthaud L., Cantrell, Jr., W.R., et al. // Nature Rev. Drug Discov. 2006. V. 5. P. 855-863.
  151. Kobayashi M. // Tetrahedron. 2002. V. 58. P. 9365-9371.
  152. Konstantinova I.D., Antonov K.V., Fateev I.V., et. al. // Int. Roundtable on Nucleosides, Nucleotides and Nucleic Acids. Lyon, 2010. P. 385-386.
  153. Averett D.R., Koszalka G.W., Fyfe J.A., et al. // Antimicrob. Agents Chemother. 1991. V. 35. P. 851-857.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Mikhailopulo I.A., Miroshnikov A.I., 2010

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах